European Experience and Evidence of Physician-led Switching of Biological Medicines Give Hope to Patients around the World
Read more
News releases
The following are news releases and statements issued by Biosimilars Canada. News stories about biosimilars that may be of interest to readers are available here.
Biosimilars Canada Statement on Revised Canadian Guidance for Sponsors of Biosimilars
The convergence of regulatory requirements is a top priority for sponsors of biosimilar medicines as single global development programs are typical given the high R&D costs for these complex products.
Canadian Generic Pharmaceutical Association Establishes First Voice for Biosimilars In Canada
The establishment of the new CGPA Biosimilars Board signifies the focus our industry is placing on ensuring that Canada is a viable market for the production and sale of biosimilar treatments.